Back

Neuronal DNA repair reveals strategies to influence CRISPR editing outcomes

Ramadoss, G. N.; Namaganda, S. J.; Hamilton, J. R.; Sharma, R.; Chow, K. G.; Macklin, B. L.; Sun, M.; Liu, J.-C.; Fellmann, C.; Watry, H. L.; Jin, J.; Perez, B. S.; Sandoval Espinoza, C. R.; Matia, M. P.; Lu, S. H.; Judge, L. M.; Nussenzweig, A.; Adamson, B.; Murthy, N.; Doudna, J. A.; Kampmann, M.; Conklin, B. R.

2025-03-17 molecular biology
10.1101/2024.06.25.600517 bioRxiv
Show abstract

Genome editing is poised to revolutionize treatment of genetic diseases, but poor understanding and control of DNA repair outcomes hinders its therapeutic potential. DNA repair is especially understudied in nondividing cells like neurons, which must withstand decades of DNA damage without replicating. This lack of knowledge limits the efficiency and precision of genome editing in clinically relevant cells. To address this, we used induced pluripotent stem cells (iPSCs) and iPSC-derived neurons to examine how postmitotic human neurons repair Cas9-induced DNA damage. We discovered that neurons can take weeks to fully resolve this damage, compared to just days in isogenic iPSCs. Furthermore, Cas9-treated neurons upregulated unexpected DNA repair genes, including factors canonically associated with replication. Manipulating this response with chemical or genetic perturbations allowed us to direct neuronal repair toward desired editing outcomes. By studying DNA repair in postmitotic human cells, we uncovered unforeseen challenges and opportunities for precise therapeutic editing.

Published in Nature Communications (predicted rank #1) · training set

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.